RxDoctor Payments Data

Xiaosong Meng

Urology · Dallas, TXNPI 1003227802

Payments from drug & device makers

$18,882in general payments, 2019–2025

Across 114 payments — averaging $165.63 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • Profound Medical Corp.$8K
  • EDAP Technomed Inc$3K
  • Angiodynamics, Inc.$3K
  • AstraZeneca$775
  • Dendreon Pharmaceuticals LLC$405
  • Medtronic$378
  • plus $4K from 27 others

What the payments were for

  • Speaking & faculty fees$2061%
  • Travel & lodging$7,14841%
  • Food & beverage$9,74956%
  • Entertainment$2802%

Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.

General payments by program year

19
20
21
22
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

What the payments were tied to

Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.

How this compares

$18,882 in reported general payments places this provider in the 80th percentile of 878 urology providers in Texas.

See all urology providers in Texas

Medicare billing

Part B allowed, 2024
$314,799
Medicare patients
313
Services billed
3,112

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

DrugClaimsCost to plans & patients
Silodosin39$2,411
Tamsulosin Hcl75$639
Nitrofurantoin Mono-MacroNitrofurantoin Monohyd/M-Cryst33$334
Finasteride35$322
Cephalexin16$42
Dexamethasone17$26
Ciprofloxacin Hcl12$26

Paid to pharmacies, not to this prescriber.

Other urology in Dallas

See the full list for Texas

Where these figures come from

Is this you, or does something look wrong? →